Boehringer's nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 versus placebo
The FIBRONEER™-ILD trial is the second Phase III trial in which the investigational compound nerandomilast has met its primary endpoint [1]
Initial safety and tolerability results of the FIBRONEER™-trials are generally consistent with the Phase II results in IPF; full efficacy and safety data from FIBRONEER™-ILD will be shared in the second quarter of 2025
Boehringer Ingelheim will submit a new drug application for nerandomilast for the treatment of PPF to the US Food & Drug Administration (FDA) and other health authorities worldwide
Boehringer Ingelheim announced today that the FIBRONEER™-ILD trial met its primary endpoint, which was the absolute change from baseline in forced vital capacity (FVC) [mL] at week 52 versus placebo. FVC is a measure of lung function. [2] Initial data readouts of the FIBRONEER™-trials support a generally consistent safety and tolerability profile when compared to the Phase II idiopathic pulmonary fibrosis (IPF) study, with overall adverse events comparable to those seen in the placebo group. 3
Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B). [3] As it has not been approved for use, safety and efficacy have not been established. It is being investigated as part of the FIBRONEER™ global program, which includes two Phase III studies —FIBRONEER™-IPF [4] in people living with IPF and FIBRONEER™-ILD [5] in people living with progressive pulmonary fibrosis (PPF).
Based on these results, Boehringer Ingelheim will submit a new drug application for nerandomilast for the treatment of PPF to the US FDA and other health authorities worldwide.
'The positive FIBRONEER™-ILD topline result shows the potential of nerandomilast in progressive pulmonary fibrosis. The hope is that the safety and tolerability profile we are initially seeing could potentially help to reduce treatment challenges,' said Shashank Deshpande, Head of Human Pharma and Member of the Board of Managing Directors at Boehringer Ingelheim. 'The recent milestones of the FIBRONEER™ trial program underscore our commitment to transforming the lives of patients with this debilitating disease, and are a testament to Boehringer Ingelheim's position at the forefront of pulmonary fibrosis research.'
About FIBRONEER™-ILD ( NCT05321082 )5
FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast (BI 1015550) over at least 52 weeks in patients with PPF.
Primary endpoint: Absolute change from baseline in FVC (mL) at week 52.
Key secondary endpoint: Time to the first occurrence of any of the components of the composite endpoint: time to first acute interstitial lung disease (ILD) exacerbation; first hospitalization for respiratory cause; or death (whichever occurs first) over the duration of the trial.
Patients participating in the FIBRONEER™-ILD trial were treated with either oral nerandomilast 9 mg or 18 mg, or placebo, twice-daily, over at least 52 weeks. The 18 mg twice-daily dose of nerandomilast is supported by the results from the Phase II study.2 An additional 9 mg twice-daily dose of nerandomilast was added to evaluate the benefit-risk profile at a lower dose, as well as to provide further dose-response and exposure-response data.2
The trial has been conducted in more than 40 countries, more than 400 locations, and enrolled 1178 patients.
About the FIBRONEER™ clinical program:
The FIBRONEER™ program includes two Phase III randomized, double-blind, placebo-controlled trials — FIBRONEER™-IPF ( NCT05321069 )4 and FIBRONEER™-ILD ( NCT05321082 )5 — to investigate the efficacy, safety and tolerability of nerandomilast over at least 52 weeks in patients with IPF and in patients with PPF.
In both trials, the primary endpoint is the absolute change from baseline in FVC (mL) at week 52.4,5 The key secondary endpoint is the time to the first occurrence of any of the components of the composite endpoint: time to first acute IPF/ILD exacerbation, first hospitalization for respiratory cause, or death (whichever occurs first) over the duration of the trials.
About nerandomilast:
Nerandomilast (BI 1015550) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for IPF and PPF.3,4,5 This compound is an investigational agent and has not been approved for use. The efficacy and safety of this investigational compound has not been established.
Nerandomilast was granted FDA Breakthrough Therapy Designation for the treatment of IPF in February 2022. [6]
The efficacy, safety, and tolerability of nerandomilast was studied in a Phase II randomized, double-blind, placebo-controlled trial of patients with IPF (n=147).3 The primary endpoint was a change from baseline in FVC (a measure of lung function) over a 12-week treatment period.3
About IPF and PPF:
IPF is one of the more common progressive fibrosing interstitial lung diseases (ILD). [7] Symptoms of IPF include breathlessness during activity, a dry and persistent cough, fatigue and weakness. [8] Although considered 'rare,' IPF affects approximately 3 million people worldwide.8, [9] The disease primarily affects patients over the age of 50 and affects more men than women.8
Patients with certain types of non-IPF fibrosing ILD may also develop a progressive phenotype known as PPF. In ILDs other than IPF, progressive pulmonary fibrosis is defined by worsening respiratory symptoms, physiological evidence of disease progression and radiological evidence of disease progression. [10]
Progressive pulmonary fibrosis can cause irreversible lung damage and lead to early mortality.10, [11]
About Boehringer Ingelheim:
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
See - Sada Elbalad
2 hours ago
- See - Sada Elbalad
Try Trending Okra Hair Mask for Stronger, Shinier & Thicker Hair
Pasant Elzaitony There's a new trend invading social media and beauty platforms, which is the okra hair mask. While it might sound unusual, it's proven effective countless times. The okra hair mask offers a variety of benefits: it moisturizes, nourishes, reduces frizz and split ends, adds natural shine, and soothes the scalp. Additionally, it may help promote hair growth and reduce dandruff. The Benefits of the Okra Hair Mask: Moisturizes Hair: Okra contains a natural gel-like substance that acts as an excellent moisturizer for dry and damaged hair, leaving it softer and more manageable. Nourishes Hair: Rich in vitamins and minerals, okra deeply nourishes the hair follicles, strengthening them and improving overall hair health and appearance. Reduces Frizz and Split Ends: This mask helps tame frizz and reduce split ends, especially at the tip, making the hair easier to style. Adds Natural Shine: Regular use of the okra hair mask gives the hair a naturally healthy shine. Soothes the Scalp: Okra has antibacterial and antifungal properties that help calm the scalp and fight dandruff. Promotes Hair Growth: Thanks to its nutrient-rich content, okra is believed to support and stimulate hair growth. Cleanses Hair: The mask also works to remove dirt and impurities from the hair and scalp. How to Use the Okra Hair Mask: Prepare the Okra: Wash the okra, cut it into small pieces, and place it in a pot of water. Boil until soft. Extract the Gel: Let it cool, then strain it using a sieve to collect the thick gel. Apply the Mask: Apply the gel evenly to your hair and scalp, ensuring full coverage. Leave it: Let the mask sit for 20–30 minutes. Rinse: Wash your hair with warm water and shampoo. You can enhance the mask by adding ingredients like coconut oil, honey, or lemon juice. You can use it once a week for best results. Contribute by Rana Atef read more 15 Ludicrous Cosplay Costumes That Will Blow You Away Watch... Dorra's natural beauty will blow your mind in latest photo session Exercising For As Little As 150 Minutes A Week Will Make You Happier، Study Claims ARIES: Your Horoscope for April 7 FDA Now Considers Vaping A Rising Epidemic In High School Lifestyle How to make Dried salted fish (feseekh) -By Chef El-Sherbini Lifestyle Batarekh Dip & Sardine Dip Lifestyle Best of Easter cookie and cakes Lifestyle ARIES friendship News China Launches Largest Ever Aircraft Carrier Sports Former Al Zamalek Player Ibrahim Shika Passes away after Long Battle with Cancer Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Business Fear & Greed Index Plummets to Lowest Level Ever Recorded amid Global Trade War Arts & Culture Zahi Hawass: Claims of Columns Beneath the Pyramid of Khafre Are Lies News Flights suspended at Port Sudan Airport after Drone Attacks Videos & Features Video: Trending Lifestyle TikToker Valeria Márquez Shot Dead during Live Stream News Shell Unveils Cost-Cutting, LNG Growth Plan Technology 50-Year Soviet Spacecraft 'Kosmos 482' Crashes into Indian Ocean Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall
Mid East Info
3 days ago
- Mid East Info
Alfa Laval launches next generation condition monitoring - Middle East Business News and Information
/INS. Alfa Laval launches Clariot™, a next generation, AI-based condition monitoring solution, precision-built for hygienic process equipment to deliver more accurate analysis and support. Clariot™ monitors equipment and processes, providing actionable insights that enhance uptime and optimize resource efficiency. ' We developed Clariot based on our extensive experience from more than 3,000 condition monitoring units already operating worldwide ', says Torsten Pedersen, Commercial Head Condition Monitoring at Alfa Laval Fluid Handling. ' With new hardware and software, we can now offer a complete digital handshake, tailored for use in demanding hygienic processes .' Every drop counts Unplanned downtime costs manufacturers billions of euro in lost revenue each year. Idle process lines cause product loss, extra cleaning, production delays, wasted water and potential damage to machinery. ' In a world where every drop and every man-hour count, our customers increasingly seek solutions that improve uptime and productivity, while reducing resource waste. This is where Clariot™ makes a difference, helping manufacturers in hygienic industries prevent failures and run at full capacity without unnecessary interruptions ', says Torsten Pedersen. Clariot™ provides 24/7 monitoring, alerts and diagnostics for pumps and other rotating equipment, e.g. agitators. The industry-intelligent solution proactively detects machine failures before they occur, maximizing performance, minimizing downtime and extending equipment lifespan. From insight to foresight Clariot™ is an important next step in the digitalization strategy of Alfa Laval, where resource and operational efficiency align with the latest smart technologies. ' We firmly believe that predictive maintenance is the future of manufacturing, enabled by sensor data, AI-driven insights and digital connectivity. Time and time again we have seen how our condition monitoring solutions have alerted operators to potential failures before they happen and enabled predictive maintenance strategies ', says Torsten Pedersen. Clariot is a standalone system, enabling maximum cybersecurity by operating independently from internal business-critical systems. Installation is simple, and Clariot™ is compatible with most pump brands. The user interface is intuitive, and the investment is low with a short payback time. ' In a setup with 50 pumps, just one unplanned stop per quarter can result in annual losses up to 80,000 euros, while the solution from Alfa Laval costs less than one tenth of that scenario, delivering a fast payback time ', says Torsten Pedersen. Comprehensive Buyers Guide available To assist decision-makers and buyers, Alfa Laval has developed a Buyer's Guide to condition monitoring in hygienic industries with detailed information about maintenance strategies, selection and implementation of the right solutions as well as customer benefits. The guideline is available for download at Facts about Clariot™ Clariot™ is an industry-intelligent, AI-based solution that detects and identifies root causes of machine failures related to process, installation and mechanical conditions. Clariot™ is designed for hygienic processes, for monitoring pumps and other rotating equipment, e.g. agitators. The Clariot VX sensor is the only sensor in the market designed specifically for wet production environments and for handling multiple change-overs on the process lines. Clariot™ VX sensors are pre-mounted on a range of Alfa Laval pumps, and the use of Clariot™ potentially extends the warranty on equipment if monitored and serviced according to recommendations. Clariot™ consists of Clariot VX sensor, Clariot Connect gateway and analytics, seamlessly integrated into a complete digital handshake. Clariot™ provides notifications that allow timely inspection and repair. Clariot™ is a stand-alone application, a cybersecure solution that meets the requirements of IEC 62443-3-3 SL1. Clariot™ is a scalable solution that allows seamless deployment across sites and benchmarking across factories. Read more on This is Alfa Laval The ability to make the most of what we have is more important than ever. Together with our customers, we're innovating the industries that society depends on and creating lasting positive impact. We're set on helping billions of people to get the energy, food, and clean water they need. And, at the same time, we're decarbonizing the marine fleet that's the backbone of global trade. We pioneer technologies and solutions that free our customers to unlock the true potential of resources. As our customers' businesses grow stronger, the goal of a truly sustainable world edges closer. The company is committed to optimizing processes, creating responsible growth, and driving progress to support customers in achieving their business goals and sustainability targets. Together, we're pioneering positive impact. Alfa Laval was founded 140 years ago, has customers in 100 countries, employs more than 22,300 people, and annual sales were SEK 66.9 billion (5.8 BEUR) in 2024. The company is listed on Nasdaq Stockholm.
Mid East Info
3 days ago
- Mid East Info
Abu Dhabi Civil Defense Authority Receives the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award
United Arab Emirates, June 19, 2025 – The National Fire Protection Association® (NFPA®) has announced that the Abu Dhabi Civil Defense Authority (ADCDA) has been selected as the recipient of the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award. The award was presented at the NFPA Stars at Night awards gala on Sunday, June 15, during the annual NFPA Conference & Expo in Las Vegas. Established in 2024, the NFPA Fire & Life Safety Ecosystem Global Influencer Award recognizes individuals or organizations who advance safety by applying and promoting the principles of the NFPA Fire & Life Safety Ecosystem™. 'We are deeply honored to receive the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award. Our strategic collaboration with NFPA has been vital in elevating our workforce capabilities and fostering a holistic safety ecosystem across the emirate of Abu Dhabi. As we continue to lead with innovation and resilience, we reaffirm our dedication to safeguarding our communities and positioning the UAE as a global benchmark for excellence in safety and emergency response,' said, H.E. Brigadier General Salem Abdulla Al Dhaheri, Director General, Abu Dhabi Civil Defense Authority. 'Abu Dhabi Civil Defense Authority has a forward-thinking leadership that is building a strategy around all elements of the Fire & Life Safety Ecosystem to achieve real-world results,' said NFPA President and CEO Jim Pauley. 'Their commitment to innovation, training, and outreach has contributed to measurable gains in public safety, including a reported 64 percent reduction in fire deaths per 100,000 people since 2021.' The ADCDA was selected for its comprehensive and sustained commitment to safety innovation, risk reduction, and capacity building across the United Arab Emirates. Of particular note is the authority's three-year certification program, developed in collaboration with NFPA, to provide advanced training for engineers, inspectors, and hazardous materials specialists. This initiative exemplifies ADCDA's investment in workforce development and operational excellence. NFPA's Fire & Life Safety Ecosystem™ emphasizes eight key components that must work together to protect people and property. ADCDA has taken a system-wide approach to address policy, enforcement, investment, education, and emergency response, serving as a model of safety leadership in the Middle East and globally. For more information about the Stars at Night awards, visit the NFPA Awards webpage. For this release and other announcements about NFPA initiatives, research, and resources, please visit the NFPA press room. About the National Fire Protection Association® (NFPA®) Founded in 1896, NFPA® is a global self-funded nonprofit organization devoted to eliminating death, injury, property, and economic loss due to fire, electrical, and related hazards. The association delivers information and knowledge through more than 300 consensus codes and standards, research, training, education, outreach, and advocacy; and by partnering with others who share an interest in furthering the NFPA mission. For more information, visit All NFPA codes and standards can be viewed online for free at
